Home -> Law Blog Directory -> Ethics Blogs -> Ethisphere Blog - Good. Smart. Business. Profit.
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Ethics
: Ethisphere Blog - Good. Smart. Business. Profit.Sanofi-aventis Pays $95.5 Million to Settle False Claims
By bpj1966
In late May, pharmaceutical company Sanofi-aventis agreed to pay $95.5 million in order to settle a charge that one of the company?s former subsidiaries intentionally violated the False Claims Act by over reporting the costs of some of its drugs.
In order to sell three of its nasal sprays?Azmacort, Nasacort and Nasacort AQ?to Medicaid, the company advertised that it sold the products to consumers at a higher value than its actual market price. This violated the Medicaid Drug Rebate Statute that requires companies to sell drugs to Medicaid for the best price that it offers to everyday consumers.
The $95.5 million will be broken down into three parts: $49 million will go to the U.S. government, $40 million will go to state Medicaid programs that overpaid for the drugs and the remainder will go to other public health entities that overpaid for the products.
Full post as published by Ethisphere Blog - Good. Smart. Business. Profit. on July 27, 2009 (boomark / email).
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
False Claims
Attorney Robert Arledge ordered to pay $5.8 million after making false Fen Phen settlement claims.
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Alta College
Settles False Claims Allegatiions for $7 Million
Atlas Cold Storage
Income Trust to pay $40 million to settle a class action that claims misrepresented financial statements.
Asarco
To Pay $2.4 Billion to Settle Asbestos-Related Claims
Vytorin Marketing
alleged false claims in marketing campaign.

Aventis Agrees to Pay $95 Million to Settle FCA Claims
Novo Nordisk Fails to Show Reasonable Likelihood of Success Over Sanofi
Judge Denies Sanofi-Aventis' Motion to Dismiss
Aventis settles FCA suit for $95.5 million
EU Antitrust Powers Not Enough for Dawn Raid
Off-label whistleblower suit dismissed









